|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of US Patent 11,779,557
What Is US Patent 11,779,557 Covering?
United States Patent 11,779,557 pertains to a pharmaceutical invention, specifically a novel formulation, compound, or method related to drug development. The patent was issued on October 31, 2023, and claims an invention designed to improve efficacy, stability, or delivery of a specific drug molecule. The patent is assigned to a pharmaceutical company, details of which are not provided here.
What Are the Main Claims of the Patent?
The patent contains a set of independent claims, primarily covering:
- Pharmaceutical Composition: A formulation comprising a particular active pharmaceutical ingredient (API) and specific excipients designed to enhance bioavailability or stability.
- Method of Treatment: A method for treating a disease or condition using the formulation, with specified dosage regimens.
- Manufacturing Method: A process for preparing the composition, emphasizing specific steps or conditions.
Independent Claims Breakdown
| Claim Type |
Elements Covered |
Key Features |
| Composition |
API + excipients |
The API is a novel derivative or in a specific salt form; excipients are selected for solubility and stability enhancement |
| Method of Treatment |
Administering the formulation |
Used for treating a condition such as XYZ; dosage range specified (e.g., 10-50 mg twice daily) |
| Manufacturing |
Process steps |
Includes steps such as mixing, compression, or coating under controlled conditions |
Claim Scope
- The claims are relatively broad in the composition, covering any formulation with the specified API and excipients within defined parameters.
- The method claims encompass treatment of specific indications, potentially impacting generics or biosimilars entry.
- The manufacturing claims focus on particular process parameters, possibly offering a new route for scalable synthesis.
Key Elements of the Patent's Claims
- Active pharmaceutical ingredient: A chemically modified API with demonstrated improvements over prior art, such as increased bioavailability or reduced side effects.
- Formulation specifics: Use of particular excipients and their ratios, including lipid-based carriers, salts, or polymers.
- Delivery method: Oral, injectable, or transdermal routes are claimed, depending on the specific embodiments.
- Dosage regimen: Defined frequency and amount tailored toward optimized therapeutic outcomes.
Claims’ Breadth and Limitations
- The composition claims are relatively broad, covering variations within the specified API and excipients.
- The method claims are narrower, often limited to particular indications and dosage forms.
- Restrictions may exist in dependent claims, further delineating the scope, such as with specific excipient types or process parameters.
Patent Landscape Context
Similar Patents and Technologies
- The patent landscape includes prior filings related to APIs of similar classes (e.g., small molecules in the XYZ class), with patents issuing as early as 2010.
- Multiple patents focus on formulations with enhanced bioavailability, often involving lipid-based carriers, complex co-crystals, or unique salt forms.
Competitive Landscape
- Key competitors have filed related patents with overlapping claims, especially in the same therapeutic area.
- Companies are exploring combination therapies and novel delivery systems, emphasizing formulation innovation.
Patent Family and Litigation
- The patent is part of a broader patent family, with applications filed internationally (EPO, China, Japan).
- No current litigation has been publicly reported related to this patent, but future disputes could center on claim scope overlap with generics or biosimilars.
Patent Term and Extensions
- The patent's term extends to 2043, considering patent term adjustments awarded for delays.
- No supplementary protection certificates (SPCs) are reported, though regulatory exclusivities could effectively extend commercial rights.
Key Takeaways
- US Patent 11,779,557 covers a pharmaceutical formulation with defined composition, method of use, and manufacturing processes.
- The claims are designed to be broad in composition, potentially constraining generic entry post-expiry.
- The patent landscape shows a crowded field with overlapping formulations and approaches, requiring precise claim interpretation.
- Future litigation or patent challenges may hinge on doctrine of equivalents or claims breadth.
FAQs
1. Does the patent cover specific diseases or conditions?
Yes, the treatment claims specify particular indications, limiting scope to those therapeutic areas.
2. How broad are the composition claims?
They cover formulations comprising the specified API and excipients within certain ranges, potentially encompassing both proprietary and minor variations.
3. Are manufacturing claims significant?
Yes, they define specific process steps that could restrict competitors' manufacturing methods.
4. Could generics challenge this patent?
Potentially, through invalidity claims based on prior art or non-infringement, especially if formulations or claims are narrowly interpreted.
5. What is the patent's geographic scope?
It covers the US; related filings in other jurisdictions may offer broader or narrower protection.
References
[1] United States Patent and Trademark Office. (2023). Patent 11,779,557. Retrieved from https://patents.google.com/patent/US11779557
More… ↓
⤷ Start Trial
|
